128 related articles for article (PubMed ID: 38650776)
1. Comparative Efficacy of Intralesional Chloroquine With Intralesional Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.
Ullah O; Rizwan M; Raza N; Zulfiqar S; Akbar N; Ullah H
Cureus; 2024 Mar; 16(3):e56785. PubMed ID: 38650776
[TBL] [Abstract][Full Text] [Related]
2. Comparison Of Efficacy Of Miltefosine Versus Meglumine Antimonate In The Treatment Of Cutaneous Leishmaniasis.
Mohammad N; Sagheer F; Paracha MM; Khan AQ; Naseem S; Wasim M
J Ayub Med Coll Abbottabad; 2022; 34(4):849-853. PubMed ID: 36566412
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
Munir A; Janjua SA; Hussain I
Acta Dermatovenerol Croat; 2008; 16(2):60-4. PubMed ID: 18541100
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Meglumine Antimoniate and Miltefosine in Cutaneous Leishmaniasis.
Rahman A; Tahir M; Naveed T; Abdullah M; Qayyum N; Malik DH; Amin B
J Coll Physicians Surg Pak; 2023 Dec; 33(12):1367-1371. PubMed ID: 38062590
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Intralesional Meglumine Antimonite along with oral Itraconazole to Intralesional Meglumine Antimonite in the treatment of Cutaneous Leishmaniasis.
Bashir U; Tahir M; Anwar MI; Manzoor F
Pak J Med Sci; 2019; 35(6):1669-1673. PubMed ID: 31777513
[TBL] [Abstract][Full Text] [Related]
6. Comparison Of Oral Dapsone With Intramuscular Meglumine Antimoniate In Cutaneous Leishmaniasis.
Ahmed N; Malik S; Tahir M; Rahman A; Fayyaz I; Raza N; Iftikhar N
J Ayub Med Coll Abbottabad; 2022; 34(4):802-806. PubMed ID: 36566403
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
Faghihi G; Tavakoli-kia R
Clin Exp Dermatol; 2003 Jan; 28(1):13-6. PubMed ID: 12558620
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A
Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
Sadeghian G; Nilfroushzadeh MA; Iraji F
Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series.
Arboleda M; Barrantes S; Úsuga LY; Robledo SM
Rev Soc Bras Med Trop; 2019 May; 52():e20180211. PubMed ID: 31141044
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oral itraconazole and intramuscular meglumine antimoniate in the treatment of cutaneous leishmaniasis.
Saleem K; Rahman A
J Coll Physicians Surg Pak; 2007 Dec; 17(12):713-6. PubMed ID: 18182133
[TBL] [Abstract][Full Text] [Related]
13. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
Yesilova Y; Surucu HA; Ardic N; Aksoy M; Yesilova A; Oghumu S; Satoskar AR
J Dermatolog Treat; 2016; 27(1):83-7. PubMed ID: 26105204
[TBL] [Abstract][Full Text] [Related]
14. Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities.
Pimentel MIF; Vasconcellos ÉCFE; Ribeiro CO; Lyra MR; Saheki MN; Salgueiro MM; Antonio LF; Schubach AO
Rev Soc Bras Med Trop; 2017; 50(2):269-272. PubMed ID: 28562769
[TBL] [Abstract][Full Text] [Related]
15. Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis.
Duque MC; Vasconcellos ÉC; Pimentel MI; Lyra MR; Pacheco SJ; Marzochi MC; Rosalino CM; Schubach AO
Rev Soc Bras Med Trop; 2016; 49(6):774-776. PubMed ID: 28001228
[TBL] [Abstract][Full Text] [Related]
16. Intralesional Versus Oral Chloroquine in Cutaneous Leishmaniasis: Comparison of Outcome, Duration of Treatment and Total Dose of Drug.
Hanif MM; Akram K; Mustafa G
J Coll Physicians Surg Pak; 2016 Apr; 26(4):260-2. PubMed ID: 27097693
[TBL] [Abstract][Full Text] [Related]
17. Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.
López L; Robayo M; Vargas M; Vélez ID
Trials; 2012 May; 13():58. PubMed ID: 22594858
[TBL] [Abstract][Full Text] [Related]
18. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
Shazad B; Abbaszadeh B; Khamesipour A
Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial.
Lago J; Fraga D; Guimarães LH; Lago T; Silva YJ; Lago E; Werneck GL; Bacellar O; Carvalho EM
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011064. PubMed ID: 36791065
[TBL] [Abstract][Full Text] [Related]
20. Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis.
Córdoba S; Gandolfo Cano M; Aguado M; Huerta-Brogera M; Romero A; Martínez-Morán C; Borbujo J
Allergy; 2012 Dec; 67(12):1609-11. PubMed ID: 23067046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]